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Abstract
Pancreas disease (PD) and sleeping disease (SD) are important viral scourges in aquaculture of Atlantic salmon and rainbow
trout. The etiological agent of PD and SD is salmonid alphavirus (SAV), an unusual member of the Togaviridae (genus
Alphavirus). SAV replicates at lower temperatures in fish. Outbreaks of SAV are associated with large economic losses of,17
to 50 million $/year. Current control strategies rely on vaccination with inactivated virus formulations that are cumbersome
to obtain and have intrinsic safety risks. In this research we were able to obtain non-infectious virus-like particles (VLPs) of
SAV via expression of recombinant baculoviruses encoding SAV capsid protein and two major immunodominant viral
glycoproteins, E1 and E2 in Spodoptera frugiperda Sf9 insect cells. However, this was only achieved when a temperature shift
from 27uC to lower temperatures was applied. At 27uC, precursor E2 (PE2) was misfolded and not processed by host furin
into mature E2. Hence, E2 was detected neither on the surface of infected cells nor as VLPs in the culture fluid. However,
when temperatures during protein expression were lowered, PE2 was processed into mature E2 in a temperature-
dependent manner and VLPs were abundantly produced. So, temperature shift-down during synthesis is a prerequisite for
correct SAV glycoprotein processing and recombinant VLP production.
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Introduction
Global fish-aquaculture has grown extensively over the past 50
years, producing yearly up to 52.5 million tons worth of an
estimated US$98.5 billion. Approximately 50% of the world’s fish
supply is derived from fish farming, of which salmon and trout
represent high value cultivates with an output of over 1.5 million
tons worth US$7.2 billion per year [1]. Unlike other reared and
farmed animals, fish are often cultured in open systems, exposing
them to a wide variety of naturally occurring pathogens, in
particular fish infecting viruses [2].
Salmonid alphavirus (SAV) is a serious pathogen for European
farmed Atlantic salmon, Salmo salar and rainbow trout,
Oncorhynchus mykiss and is the etiological agent of pancreas
disease (PD) and sleeping disease (SD), respectively. PD is
associated with lack of appetite, lethargy, pancreatic and heart
lesions and increased mortality up to 48% of infected fish [3]. SD
is characteristically presented by fish lying on their side on the
bottom of the culture tank due to severe skeletal muscle necrosis
[4]. SAV is an unusual alphavirus and differs from other
alphaviruses like Sindbis virus (SINV), Semliki forest virus (SFV)
or Chikungunya virus (CHIKV) as it solely replicates in fish
(mainly salmonids) and has no known arthropod vector. Although
SAV has successfully been detected in parasitic salmon louse
species, the supposition of lice being a vector for SAV transmission
remains to be proven, since active SAV replication within lice has
not yet been confirmed [5,6]. In addition, it has been shown that
SAV can be transmitted from fish to fish in cohabitation
experiments in the absence of an arthropod vector [7] [8].
SAV belongs to the genus Alphavirus within the Togaviridae
family and represents at least six closely related subtypes, of which
three are of special interest: salmon pancreas disease virus (SPDV
or SAV1) from Ireland, sleeping disease virus (SDV or SAV2)
from France and the Norwegian salmonid alphavirus (NSAV or
SAV3) [3]. SAV virions are enveloped spherical (,65 nm)
particles and contain a positive sense, single-stranded RNA
genome of approximately 12kb [9]. The viral RNA encodes two
open reading frames (ORF); the non-structural ORF, which is
directly translated from the genomic RNA, and the structural
ORF, which is encoded by a 26S sub-genomic mRNA and is
processed into 5 structural proteins – capsid, E3, E2, 6K, and E1.
SAV transmembrane glycoproteins E1 and E2 are exposed on the
virion surface as trimeric spikes, facilitating cell receptor
recognition (presumably E2), cell entry via pH-dependent
endocytosis (presumably E1) and support budding. E2 also serves
an important role in regulating the fusion activity of E1 so that this
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does not occur before endocytosis [10]. The acidic endosomal
environment dissociates the trimeric spike and causes E1 to initiate
fusion with the endosomal membrane [11,12], thereby releasing
the nucleocapsid and subsequently the viral RNA into the
cytoplasm of the cell.
During translation of the structural polyprotein, the capsid
protein is autocatalytically cleaved off from the structural
polyprotein to encapsidate newly synthesized genomic RNA.
The remaining envelope cassette (E3-E2-6K-E1) is subsequently
translocated to the endoplasmic reticulum (ER) and is processed
by host signalases at the N-terminal and C-terminal end of 6K,
yielding E3E2 (precursor E2; PE2), 6K and E1[13]. The
membrane anchored PE2 and E1 form heterodimers and three
PE2-E1 dimers will eventually assemble into heterotrimers in the
rough ER of infected cells [14,15,16,17]. The presence of E3
within the heterotrimers offers resistance against the acidic
environment of the Golgi apparatus, to avoid premature trimer
activation by homotrimerization of E1 [13]. In the trans-Golgi
system, PE2 undergoes furin-dependent maturation, thereby
releasing E3 from E2. However, E3 may remain associated with
the E1-E2 trimers in the acidic compartments of the cell and
dissociates once the trimers reach the cell surface to prime the
spikes for acidic activation [18].
SAV infection in farmed salmonids can be minimized by
reducing stress and good hygienic culture methods, such as sea-lice
control and proper boat and transporter cleaning and disinfection.
Next to these control measures, vaccination in fish has shown to be
effective in protecting farmed salmon and trout from SAV
infections. Few studies have focused on SAV-specific immune
responses in fish, but it has been shown that infected salmonids
generate a short-lasting (,9 months) protective immune response
against subsequent SAV infections [19] and that, similar to other
alphaviruses, immune cells are involved in dissemination of
infection in the host [20,21]. Although the immune response
against SAV is not fully understood, it has been demonstrated in
multiple studies that salmonids can be protected against SAV
challenge by immunization with inactivated virus formulations
and that immunized fish elicit neutralizing antibodies, resulting in
viral clearance [8,22]. Several vaccination strategies have been
developed and tested, such as formalin-inactivated viral vaccines,
recombinant and attenuated live vaccines [3,23,24,25,26]. Al-
though these vaccines provide cross-protection to all SAV-
subtypes, safety issues such as incomplete inactivation of active
virus remain problematic. The use of a subunit vaccine may serve
as an elegant alternative for inactivated or live-attenuated
vaccines, in particular the use of virus-like particles (VLPs). VLPs
are non-pathogenic virus look-alikes, since they are morpholog-
ically similar to virions but are non-infectious as they do not
contain viral RNA. Recent studies have shown that the expression
of the CHIKV-structural polyprotein in culture cells results in the
formation of VLPs, which induced a protective immune response
in non-human primates [27]. However, the low temperature
replication and assembly of SAV are potentially major hurdles to
the production of SAV VLPs.
This study focuses on the genesis of SAV VLPs using the
recombinant baculovirus-insect cell expression system. This
expression system has proven to be an efficient and safe way to
express heterologous proteins on large scale in insect cells, which
resulted in the production of several commercially available
human and veterinary viral vaccines [28,29,30,31,32]. The
recombinant insect cell expression system is based upon the
exchange of the baculovirus polyhedrin gene for the heterologous
gene of interest. Polyhedrin expression is controlled by the strong
polyhedrin promoter, thereby enabling high heterologous protein
expression. Next to high level protein expression, insect cells
enable post-translational protein modification and accurate folding
[29,33] and several studies have shown efficient alphavirus protein
expression, using recombinant baculoviruses [34,35,36]. In
addition, the baculovirus-insect cell expression has been shown
to be an elegant method for VLP production of enveloped and
non-enveloped arboviruses [37]. In this study, we show that the
formation of SAV VLPs in insect cells does not take place under
standard conditions, but that it is dependent on the level of
processing of the envelope glycoprotein E2. In addition, we show
that E2 processing is a function of temperature and is only
complete at low temperatures. Finally, we present an optimized
production process involving a temperature-shift regime to allow
the efficient secretion of SAV VLPs in the culture fluid of
baculovirus-infected insect cells.
Materials and Methods
Cells and viruses
Adherent Spodoptera frugiperda (Sf9) cells (Invitrogen) were
maintained as monolayer cultures in Sf-900 II medium (Gibco),
supplemented with 5% fetal calf serum. Recombinant baculo-
viruses were generated using a modified Autographa californica
multicapsid nucleopolyhedrovirus (AcMNPV) backbone. Promot-
er sequences and large parts of the coding sequences of cathepsin
and chitinase were deleted from the bacmid backbone [38]. The
resulting AcDcc was further modified by deletion of the p10
promoter and ORF. These elements were replaced by a zeocin
resistance marker by Lambda Red recombination [39,40].
Modified LoxP sequences flanking the zeocin resistance marker
were used for subsequent removal of the resistance marker by Cre
recombinase [41]. The pFastBac1/SAV3 was constructed by
cloning the SAV3 structural polyprotein (Genbank accession #
AY604235) as a 3957 nt EcoRI-XbaI fragment into pFastBAC1
(Invitrogen). The recombinant baculovirus AcDccDp10 expressing
the structural cassette of SAV3 was generated using the Bac-to-Bac
baculovirus expression system (Invitrogen), resulting in Ac-SAV3.
Recombinant baculovirus titers expressed as tissue culture
infectious dose 50 (TCID50) per ml, were determined by end
point dilution [42]. All infections were performed in serum-free Sf-
900 II medium.
Recombinant baculovirus infections and temperature-
shift assay
To analyze protein expression and processing, 1.56106 Sf9-cells
were seeded in a 6-wells culture plate and infected with Ac-SAV3
at a multiplicity of infection (MOI) of 10 TCID50 units per cell.
Infections were performed at 27uC on a shaking platform.
Subsequent incubations were performed at 12uC, 15uC, 18uC or
27uC for 14, 10, 7 and 3 days, respectively. The medium fraction
was removed and cells were harvested, washed once in phosphate
buffered saline (PBS), resuspended in 200 ml PBS and stored at
220uC. To analyze the effect of a temperature-shift on protein
processing, cells were infected and harvested as previously
described, but were initially incubated at 27uC. Next, cells were
transferred to 12uC, 15uC or 18uC at 24hpi, 48hpi or 72hpi.
Protein analysis
Secreted protein fractions were precipitated by 7% (w/v) NaCl,
2.3% (w/v) polyethylene glycol (PEG)-6000 precipitation. Pellets
were resuspended in 100 ml PBS and stored at -20uC. Whole cell
lysates and medium fractions were analyzed by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and
Coomassie brilliant blue (CBB) staining. Denatured proteins were
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transferred to an Immobilon membrane (Millipore) and examined
by western analysis. Membranes were blocked with 3% skim milk
in PBS-0.1% Tween-60 (PBST) for 1 h at room temperature (RT).
Membranes were washed in PBST and incubated for 1h at RT
with 1:2000 diluted primary monoclonal antibody (mab) a-E2
17H23 (SAV3) [43] and a-E1 (raised against the N-terminus of
SAV3 E1, aa 1-26) in PBST, supplemented with 0.2% skim milk.
Membranes were washed 3 times with PBST and incubated for 45
minutes at RT with 1:3000 diluted Alkaline Phosphatase (AP)
conjugated secondary antibody, in PBST supplemented with 0.2%
skim milk. Membranes were washed three times in PBST and
incubated with AP-buffer for 10 min. Proteins were detected by
NBT/BCIP staining (Roche). Antigenic mass was determined by a
sandwich immune-capture ELISA using the monoclonal a-E2
17H23 (SAV3) antibody [43].
PNGase F treatment
Protein fractions were treated with PNGase F (New England
Biolabs) to analyze the glycosylation status of SAV3-E2. Cell
fractions and the precipitated medium fraction were treated with
1 ml glycoprotein denaturing buffer in 9 ml MilliQ for 10 min at
100uC. The denatured protein-mix was incubated for 1 h at 37uC
with 2 ml 10x G7 reaction buffer, 2 ml 10% NP40, 1.5 ml PNGase
F and 4.5 ml MilliQ. Treated proteins fractions were analyzed with
SDS-PAGE, western blot (WB) and CBB.
Immunofluorescence assay
Sf9-cells were seeded on glass coverslips in 24-wells plate,
infected and incubated at 12uC, 15uC, 18uC and 27uC. Cells were
fixed with 4% paraformaldehyde in PBS for 5 min at RT, washed
with PBS and subsequently incubated with PBS containing 1:2000
diluted primary monoclonal mouse a-E2 antibody [43] for 1 h at
RT. Cells were washed carefully with PBS and treated with 1:1000
diluted goat a-mouse polyclonal Alexa 546 (Invitrogen) for 1 h at
RT in dark conditions. Next, cells were washed and coverslips
were fixed on glass slides with a drop of antifade fluoromount-G
(Southern Biotech). Cells were analyzed by laser confocal
microscopy on a Zeiss LSM 510 Meta, Axiovert 100 m.
Electron microscopy analysis
Copper 400 square mesh grids (Veco) were hydrophilized by
Argon gas discharge. Next, 10 ml sample was applied for 2 min
and the excess liquid carefully removed. The grid was washed 5x
with MilliQ and stained with 2% uranyl acetate for 20 s. Excess
dye was removed, grids were air dried and analyzed with a JEOL
JEM 2100 transmission electron microscope. Analysis of fixed cell
samples was performed as described [44].
Results
Expression of SAV3 structural cassette in Sf9 insect cells
by recombinant baculoviruses
A recombinant baculovirus was generated (Ac-SAV3) to express
the complete SAV3 structural cassette C-E3-E2-6K-E1 (Fig. 1A).
The complete coding sequence of the structural cassette was
cloned downstream of the polyhedrin promoter of an adapted
AcMNPV backbone. Insect cells were infected with a MOI of 10
TCID50/cell and were incubated for 72 h. Protein expression in
the cell fraction was analyzed by CBB and WB using a-E1 and a-
E2 mabs. Total protein-staining by CBB showed high levels of
expression based upon the abundant band of approximately
35 kDa, which closely matches the predicted size of the SAV
capsid protein (Fig. 1B, left). Western analysis using a-E1 and a-E2
mabs yielded bands of ,50 kDa and ,55 kDa, respectively
(Fig. 1B, center). These sizes correspond to the predicted
molecular mass of E1 (49.2 kDa) and E3E2 (54.8 kDa), suggesting
that expression of the SAV3 structural cassette results in an E3E2
intermediate that is not further processed by host furin.
To analyze if SAV glycoproteins were glycosylated (Fig. 1C),
expression products were treated with PNGase F, which
enzymatically removes carbohydrate residues from proteins.
SAV3-E2 is predicted to be N-glycosylated at N318 (Fig. 1A)
[17,45]. As expected, PNGase F treatment reduced the size of
E3E2 with a few kDa (Fig. 1C). The shift in molecular mass of the
SAV3-E3E2 fraction after PNGase F treatment suggests that
SAV3-E2 is indeed N-glycosylated, when expressed in Sf9 insect
cell by recombinant baculoviruses. The absence of non-glycosy-
lated protein fraction in the untreated sample indicates that SAV3-
E2 is very efficiently glycosylated in insect cells, despite the fact
that E3 is not released from E3E2 by furin cleavage. Infected cells
displayed baculovirus-specific cytopathic effect (CPE) including
decreased cell growth, enlarged nuclei and cell monolayer
detachment. However, Sf9 cells infected with Ac-SAV3 showed
additional CPE. Cell membranes fused between closely neighbor-
ing infected cells resulting in polykaryons or syncytia (Fig. 1D).
This syncytia formation was most likely induced by the fusogenic
activity of SAV-E1, since alphavirus E1 regulates fusion during
endocytosis in wildtype infections [17]. In addition to the enlarged
nuclei and syncytia, infected Sf9 cells contained dense nuclear
bodies that were only detectable in cells expressing the SAV
structural cassette (Fig. 1D and Fig. 2A, indicated with arrows)
Nuclear staining using Hoechst suggested that the nuclear bodies
contained nucleic acids (Fig. 1D).
To further investigate the nature of these nuclear bodies,
infected cells were fixed and embedded in gelatin after which the
cells were analyzed by transmission electron microscopy (TEM)
(Fig. 2B). All infected cells developed the dense structures which
appeared to consist of aggregated, smaller spherical structures,
surrounded by a halo of viral stroma. Based on morphology and
size (,30 nm) and the fact that SAV3-capsid contains a nuclear
localization signal [46], the spherical structures corresponds most
likely to assembled SAV nucleocapsids.
Temperature-dependent processing of SAV3 structural
proteins
The analysis of the SAV3 structural cassette, expressed by
recombinant baculoviruses at 27uC, showed that SAV3-E2 was
efficiently glycosylated, but was not released from its E3E2
precursor by host furin-like proteases. Since SAV is an alphavirus
of cold-water fish, the lack of furin-processing in E3E2 might be
caused by the significant difference in environmental temperature
between wildtype SAV replication (12-15uC) [3] and baculovirus
expression (27uC). To investigate this putative temperature-effect
on furin-dependent processing, Sf9-cells were infected with Ac-
SAV3 and incubated at 12uC, 15uC, 18uC and 27uC for 14, 10, 7
and 3 days, respectively. Whole cell lysates were treated with
PNGase F and analyzed using WB. Expression at 27uC (Fig. 3A,
lane 2) resulted in similar protein patterns as seen before (Fig. 1B).
The 55 kDa protein band, corresponding to glycosylated but
unprocessed SAV-E3E2, was also detected at all lower expression
temperatures (Fig. 3A, lane 3, 4, 5). However, in addition to E3E2,
a second protein band of lower molecular mass was found. The
smaller polypeptide (48 kDa) matches the predicted molecular
mass of processed SAV3-E2 (46.9 kDa). This suggests that furin
cleavage of E3E2 is rescued at 18uC, 15uC and 12uC. At all
temperatures, PNGase I treatment resulted in an equal downward
shift of both bands, suggesting that recombinant E3E2 and E2
were N-glycosylated (data not shown). From the relative intensities
Low Temperature Salmonid Alphavirus VLP Formation
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of the bands on the WB, it could be concluded that the intensity of
the E2 fraction increased at lower temperatures. In conclusion, by
decreasing the expression temperature from 27uC to 18uC, 15uC
or 12uC, the ratio between E3E2 and fully processed E2 shifts
towards the processed fraction (Fig. 3B). These results suggest that
furin processing of the SAV3 E3E2 precursor is temperature
dependent. Medium fractions of Ac-SAV3 infected Sf9 cells were
PEG-precipitated to concentrate protein content and western
analysis using a-E2 mabs showed that E2 can be detected in the
medium fraction (Fig. 3C), but only when proteins were expressed
at 12uC, 15uC or 18uC, but not at 27uC.
Surface expression of baculovirus expressed SAV3-E2 in
Sf9 cells
To generate progeny viral particles through budding, alphavirus
glycoproteins assemble into heterodimers, three of which congre-
gate into trimers, the so-called trimeric spikes. The spikes are
formed in the ER and pass through the Golgi apparatus. At the
end of the processing pathway, the trimeric spikes are anchored in
the plasma membrane by the C-terminal transmembrane domains
of E1 and E2 and are exposed on the surface of infected cells [17].
So far, it has been shown that expression of the SAV3 structural
cassette by recombinant baculoviruses in insect cells results in the
formation of glycosylated E3E2, which, at lower temperatures, is
processed to glycosylated E2. This suggests that processing in
insect cells resembles the processing as it takes place during
wildtype infections in fish cells. In this case, glycoprotein spikes are
exposed at the insect cell surface [13]. To analyze whether or not
this is true, Sf9 cells were infected with Ac-SAV3 at different
temperatures. Next, non-permeable cells were subjected to
immunofluorescence using a-E2 mabs (Fig. 4). Positive staining
indicates that SAV3-E2 is exposed at the surface of the cells.
Confocal microscopy revealed that the ring-like structures
indicating surface expression could only be observed when Ac-
SAV3 was expressed at 12uC, 15uC and 18uC. (Fig. 4). In sharp
contrast, surface expression of E2 was not detected at 27uC (Fig. 4),
while western analysis showed that E3E2 was expressed at high
levels (Fig. 3A). No staining was observed in the mock cells (Fig. 4,
left). These data comply with the previous results and demonstrate
that the processing of SAV3-E2 is temperature dependent and that
Figure 1. SAV3 structural cassette expression, using recombinant baculoviruses. A) Schematic representation of the SAV3 structural
cassette as it is expressed by recombinant baculoviruses. The molecular mass of the proteins are indicated and shaded areas represent
transmembrane domains or signal sequences (ss). Autocatalytic (A), furin (F) and signalase (S) cleavage sites are indicated, asterisks represent N-linked
glycosylation sites. B) Protein expression in Sf9 cells was analyzed by CBB and WB using SAV a-E1 and SAV a-E2 mabs. C) Whole cell lysates were
treated with/without PNGase F and analyzed with SAV a-E2 mabs. D) Cells infected with Ac-GFP and Ac-SAV3 and stained with Hoechst. CPE was
evaluated by brightfield and fluorescence microscopy. Arrows indicate dense nuclear bodies in Ac-SAV3-infected insect cells.
doi:10.1371/journal.pone.0025816.g001
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E2 can only be detected at the surface of infected cells at lower
temperatures.
SAV3 virus-like particle formation in Sf9 cells expressing
the SAV3 structural cassette
Processing of the SAV3 structural cassette, expressed by
recombinant baculoviruses in insect cells is temperature depen-
dent. Mature E2 is produced at temperatures ranging between
12uC and 18uC, where it is then translocated to the surface of Ac-
SAV3 infected cells and subsequently can be detected in the
medium fraction. In addition, it was shown that the capsid protein
is successfully auto-cleaved from the structural polyprotein (Fig. 1B,
left) and E1 is successfully released from the envelope cassette
(Fig. 1B, middle). When the structural cassette was expressed at
27uC, E2 retained in the cell fraction in its E3E2 precursor form
(Fig. 3A, lane 2). The effect of temperature on SAV maturation is
clear, but to asses if temperature has an influence on the
antigenicity of recombinant SAV-E2, which carries the major
neutralizing epitopes, an immune-capture antigenic mass ELISA
using the SAV neutralizing mab (17H23) was performed on total
cell culture lysates and medium fraction of Sf9 cells infected with
Ac-SAV3 at 27uC, 18uC, 15uC and 12uC (Fig. 5A). The highest
antigenic mass was detected in the combined sonicated culture
fraction and medium fraction of cells incubated at 15uC. Slightly
lower antigenic mass levels were detected at cells incubated at
18uC and 12uC, whereas no antigenic mass was detected at 27uC.
Detection of high antigenic mass in the medium fraction of
infected cells incubated at 15uC or lower, suggested the formation
of SAV VLPs. To investigate whether or not SAV VLPs could be
detected, the 15uC medium fraction was evaluated by transmission
electron microscopy (TEM) (Fig. 5B). VLP structures – spherical,
sometimes donut-shaped, particles of 65–70 nm – that were
morphologically similar to SAV3 virus particles (Fig. 5B, left) were
found (Fig. 5B, middle), but these were absent in the control
medium of Ac-GFP infection (Fig. 5B, right). This shows that SAV
VLPs can be produced by expressing the SAV3 structural cassette,
using the recombinant baculovirus-insect cell expression system.
Moreover, these VLPs can be detected by a SAV-neutralizing
mab, suggesting that these VLPs morphologically and antigeni-
cally resemble authentic SAV virions.
SAV3 structural cassette expression and VLP formation
by temperature-shift in Sf9 insect cells
The results so far have shown that SAV glycoprotein processing
and secretion and VLP formation is dependent on the expression
temperature. Although SAV-E2 processing appears to be most
efficient at 12uC (Fig. 3A), expression at this temperature remains
inefficient, due to the low metabolic rate of Sf9 cells and the
extensive incubation time of 14 days. To optimize insect cell
infection and SAV3 structural polyprotein processing, a temper-
ature-shift experiment was performed. In this experiment, Sf9 cells
were first infected with Ac-SAV3 at 27uC for 2 days to allow
efficient baculovirus replication, after which the cells were
transferred to 12uC for 3 days, to allow expression of properly
processed SAV structural proteins. Protein expression, E2
processing, surface localization and VLP formation was analyzed
5 dpi by WB and immunostaining using a-E2 mabs and by TEM
(Fig. 6). The temperature-shift resulted in increased processing of
Figure 2. Nuclear localization and assembly of SAV3-nucleocapsids. Sf9 infection with Ac-SAV3 and Ac-GFP was analyzed by A) light-
microscopy at 2 d.p.i. B) Ac-SAV3-infected cells were fixed and embedded in gelatin and ultrathin coupes were analyzed by TEM, with C, N, VS and NC
indicating cytoplasm, nucleus, virogenic stroma and SAV nucleocapsids, respectively.
doi:10.1371/journal.pone.0025816.g002
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SAV3-E2 (Fig. 6A, lane 3), as compared to 27uC expression
(Fig. 6A, lane 2), since both E3E2 (,55 kDa) and mature E2
(,48 kDa) were detected. PNGase F treatment led to a decrease in
molecular mass, showing that both E2 configurations were
glycosylated (Fig. 6A, lane 4). Immunostaining on non-permeable
Sf9 cells that were infected following the temperature-shift regime
showed that E2 was detected on the surface of infected cells
(Fig.6B), similar to results found after 12uC incubation (Fig. 4). In
contrast, surface staining of the cells infected at 27uC were
negative (Fig. 6B). In addition, medium of infected Sf9 cells with
the temperature-shift was examined by electron microscopy
(Fig. 6C). Characteristic VLP structures were again detected,
which were similar to those found after expression at 15uC
(Fig. 5B).
To further optimize the VLP formation in a temperature-shift
regime, Sf9 cells were infected with Ac-SAV3 at 27uC and
transferred to 12uC, 15uC and 18uC at 1 dpi, 2 dpi and 3 dpi. Cells
were subsequently incubated for 3 days at the indicated
temperatures. As controls, cells were infected and incubated for
a total of 6 days at 12uC, 15uC and 18uC. Both cell and PEG-
precipitated medium fractions were analyzed by western analysis
using a-E2 mabs (Fig. 7). SAV3-E2 was not detected in both the
cell and medium fraction of cells that were infected at 27uC for 1
day (Fig. 7, lane 1). However, when cells were subsequently
incubated for three days at lower temperatures, E2 was
abundantly detected in both cell and medium fractions (Fig. 7,
lane 2-4), indicating a strong increase in processing efficiency due
to the temperature shift. Cells that were infected at 27uC for 2 days
produced a low amount of E3E2. Although less pronounced than
the shift after 1 dpi, the temperature-shift to lower temperatures 2
dpi increased processing and detection of E2 in the cell and
medium fractions (Fig. 7, lane 5–8). Here, a shift to 15uC appeared
optimal (Fig. 7, lane 7). Infection for 3 days at 27uC, as expected,
appeared to be highly disadvantageous for the processing and
secretion of E2, since only unprocessed E3E2, but no mature E2
was detected in both cell and medium fractions (Fig. 7, lane 9). It
was concluded from this large temperature-shift experiment that
infection for 1 day at 27uC followed by expression for 3 days at
15uC was optimal for E2 expression, processing and VLP secretion
into the medium. In addition, this temperature-shift regime of in
total 4 days significantly shortens infection time as compared to a 6
day infection at 15uC (Fig. 7, lane 14).
Discussion
SAV infections cause severe economic losses in European
aquaculture of Atlantic salmon and rainbow trout. Next to
common infection control measures, vaccination is a most effective
tool to reduce SAV infections in salmonids. The presently
available vaccines are based upon inactivated or attenuated-live
vaccine strategies. However, a VLP-subunit approach may serve
as an elegant and effective alternative to the safety issues that
accompany the present way of vaccine production. The recom-
binant baculovirus-insect cells expression system has proven to
have a high potential in the generation of VLP-subunit vaccines
[29,36]. In this study, SAV VLPs were generated using
recombinant baculoviruses and it was shown that the processing
of SAV glycoproteins is a temperature-dependent process. VLP
formation in insect cells at the normal production temperature of
27uC is not possible.
The SAV3 structural cassette (C-E3-E2-6K-E1) was cloned
downstream of the polyhedrin promoter of AcMNPV (Ac-SAV3)
and expressed in Sf9 insect cells. SDS-PAGE and CBB analysis
indicate that the SAV structural (glycol)proteins were expressed in
high amounts and that the capsid protein was autocatalytically
released from the structural polyprotein, similar as in wildtype
alphavirus infection [17,47]. Alphavirus capsids are multifunc-
tional proteins that are involved in encapsidation of viral genomic
RNA, viral budding and in New-world alphaviruses induce host-
cell transcription/translational shut-off [17,48]. Depending on the
alphavirus species and the cell type used for expression, capsid
localizes in several cellular compartments e.g. cytoplasm, nucleus/
nucleoli and mitochondria [46,48,49,50]. Infection of Sf9 cells with
Ac-SAV3 resulted in the formation of dense nuclear bodies, which
appeared to be specific for cells expressing the SAV structural
polyprotein. In addition, Hoechst staining showed that nucleic
acids co-localized with the dense nuclear bodies and TEM analysis
confirmed the in silico predicted nuclear localization of capsid [46].
This is the first report that shows the presence of assembled
alphavirus nucleocapsids of ,30 nm in the nucleus of insect cells.
The expression of the SAV-structural cassette in Sf9 cells at
27uC clearly prevented complete processing of E2. In this regard,
the efficient glycosylation of SAV glycoproteins is remarkable,
since our other work showed that CHIKV glycoprotein expression
Figure 3. Temperature-dependent processing and secretion of
SAV-E2. A) Sf9 cells were infected with Ac-SAV3 with an MOI of 10 at
27uC, 18uC, 15uC and 12uC. SAV-E2 expression in the cell-fraction was
analyzed by WB using SAV a-E2 mab (17H23). B) Relative percentages of
SAV-E3E2 and E2, indicating more efficient processing of E3E2, with
decreasing temperatures. C) Secretion of E2 as a function of the
temperature. The medium fraction of infected Sf9-cell cultures was PEG-
precipitated and analyzed by WB using SAV a-E2 mab.
doi:10.1371/journal.pone.0025816.g003
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by recombinant baculoviruses resulted only in partial glycosylation
[36].
Processing of SAV-E2 by host-furin cleavage was rescued after
decreasing the infection temperatures to 18uC, 15uC or 12uC.
Immunostaining indicated that only correctly folded proteins were
recognized by the a-E2 mab, since at 27uC E3E2 could be
detected under denaturing conditions by western analysis, but was
not detected by immunostaining in permeabilized cells infected
with Ac-SAV3. It has previously been shown that the 17H23 mab
recognizes a discontinuous epitope (aa139-306) [43] on SAV3-E2.
Incorrect folding of native PE2 might prevent the binding of mab
17H23 to the epitope, while under denaturing conditions, the
conformational epitope is restored, thereby allowing antibody
recognition by western analysis. Similar epitope-reformation
under standard denaturing conditions has previously been
described for other viral denaturation-resistant epitopes [51,52].
The incorrect folding of PE2, at 27uC that prevents binding of
mab 17H23 might also render the SAV-PE2 furin-cleavage signal
68RKKR inaccessible to host furin-like proteases. An alternative
explanation is that cellular furin is inactive at 27uC, however, this
is highly unlikely given that baculovirus F protein is also activated
by furin at similar temperatures (26uC–28uC) [53]. The apparent
prevention of furin cleavage itself does not fully explain the
absence of E3E2 in the medium at 27uC, because furin cleavage is
not a prerequisite for alphavirus budding or E3E2 secretion
[36,54,55]. The deficiency in E3E2 processing and lack of secreted
E3E2 at 27uC, is therefore most likely caused by the retention of
misfolded SAV-E3E2 in the ER or secretory pathway, in any case
upstream of the trans-Golgi system where furin-dependent
maturation takes place [13]. Misfolded and unfolded proteins
usually accumulate in the ER, causing ER stress and thereby
disrupting ER functions [56], a phenomenon often observed
during overexpression of glycoproteins by recombinant baculo-
viruses [57]. It will be important to investigate in future
experiments which structural change of E3E2 determines its
intracellular retention at 27uC.
We show by electron microscopy that recombinant baculovirus
expression of the SAV structural cassette in Sf9 cells at lower
Figure 4. SAV3-E2 detection on the surface of Sf9 cells after recombinant baculovirus expression. Cells were infected with Ac-SAV3 at
12uC, 15uC, 18uC and 27uC. Cells were fixed with 4% paraformaldehyde and subjected to immunostaining with a-E2 mabs. Cells were analyzed by
confocal microscopy and positive staining indicates the presence of E2 at the surface of infected cells.
doi:10.1371/journal.pone.0025816.g004
Figure 5. SAV-E2 antigenic mass determination and VLP
production. A) SAV-E2 antigenic mass was determined using the
SAV-neutralizing mab 17H23 on cell and medium fractions of infected
Sf9-cells, incubated at 27uC, 18uC, 15uC and 12uC. B) The medium
fraction of cells infected with Ac-SAV3 at 15uC was analyzed by TEM to
analyze SAV VLP production. Medium fractions of Ac-GFP infected Sf9
cells and SAV3 infected Chinook salmon embryo cells were used as
control samples.
doi:10.1371/journal.pone.0025816.g005
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temperatures results in the formation of SAV VLPs. This result
was confirmed by western analysis on the medium fraction of
infected cell cultures and by sandwich immune-capture ELISA on
infected cells and/or medium, in which SAV proteins were only
detected at expression temperatures below 27uC. The spherical
particles of ,65 nm in size, morphologically indistinguishable
from SAV3 virus particles and other alphavirus VLPs [27], were
found exclusively in the medium of Ac-SAV3 infected Sf9 cells at
lower temperatures, but not in the medium of control baculovirus
lacking SAV sequences or mock-infected Sf9 cells.
Since total production levels of recombinant SAV protein were
the highest at 27uC, while lower temperatures were essential for
PE2 processing, a hybrid protein production process, with an
infection phase at 27uC followed by a production/processing
phase at 12uC was developed.
Immunostaining and western analysis showed that recombinant
SAV proteins produced following the temperature regime,
appeared to be folded and processed correctly, and as expected,
SAV VLPs were detected in the medium fraction of Ac-SAV3
infected cells. The temperature-shift production and processing
regime was further optimized by varying the production time at
27uC. Both cell and medium fraction analysis showed that a 1 day
infection phase at 27uC, followed by a 3 day processing phase at
15uC was optimal for combined protein expression and processing
efficiency. In addition, it appeared that the vast majority of VLPs
produced at 15uC have mature SAV-E2 incorporated in their
envelope. However, PE2 medium detection indicated that, in a
small fraction of VLPs, E3 was still associated to the trimeric
spikes. This common alphavirus feature does not affect cell
receptor recognition by E2 [58]. Thus, we expect VLPs carrying a
minor E3E2 fraction still to be sufficiently immunogenic, especially
considering that E3 from other alphaviruses harbors protective
epitopes [59].
In addition to SAV VLPs, also the insect cells expressing
correctly folded SAV structurals may be used in veterinary vaccine
formulations. Similar to the widely used baculovirus surface
display technique, based upon the expression of foreign peptides/
epitopes using a chimeric baculovirus GP64 surface glycoprotein
[60], SAV glycoproteins are anchored in the insect cell membrane
and are displayed at its surface. However, the baculovirus surface
display technique may find limited use in SAV glycoprotein
production, since the preceding alphavirus E3 peptide with signal
sequence is required for correct E2 folding and the use of
heterologous signal peptides has recently been shown not to
enhance alphavirus glycoprotein production [36].
The temperature-shift clearly rescues SAV glycoprotein
processing, most likely via restoring upstream protein misfold-
ing. A similar temperature-dependent folding phenomenon has
previously been described for a temperature sensitive mutant of
the vesicular stomatitis virus glycoprotein (VSV-Gmut). VSV-
Gmut accumulated in the ER due to misfolding at 40uC, but
was refolded when the temperature was decreased to 32uC,
enabling VSV-Gmut to enter the secretory pathway into the
Golgi-complex [61]. In future studies we would like to investi-
gate the molecular mechanisms of presumed SAV glycoprotein
misfolding at high temperatures, but it is unlikely that this will
lead to a more efficient VLP production process at 27uC in the
short term.
We clearly show that the initial incubation period for 1 day at
27uC following inoculation with baculovirus is of high importance
for efficient VLP production. Nonetheless, extension of the 27uC
baculovirus infection phase, negatively influenced SAV-PE2
processing and inhibited the formation of SAV VLPs. The strong
CPE associated with baculovirus infection that usually occurs 2–3
dpi is most likely disabling cells to rescue SAV glycoprotein folding
and processing after the shift to lower temperatures. However, a
one day 27uC infection phase is highly beneficial and combined
with a three day production processing phase at 15uC significantly
shortens the time it takes to produce similar SAV E2 proteins
levels as a six day production period at 15uC. This embodies a
major advantage for large scale industrial antigen production in
insect cell-bioreactors.
This study provides clear evidence that recombinant SAV VLPs
can be produced in insect cells using baculovirus expression but
also that SAV glycoprotein processing and folding is strictly
temperature dependent and a critical determinant of VLP
production. The proposed temperature-shift regime not only
optimizes SAV VLP production in insect cells, but also provides a
general principle for other vaccine candidates of cold-blooded
infectious agents in insect cell systems. We aim to address the
immunogenicity of our SAV VLPs in a follow up study involving a
vaccination trial.
Figure 6. SAV3 structural cassette expression and VLP
formation by temperature-shift in Sf9 insect cells. Sf9 cells were
infected with Ac-SAV3, incubated for 2 days at 27uC and subsequently
transferred to 12uC for 3 days. A) Cell cultures were treated with/
without PNGase F and analyzed by WB using a-E2 mabs. B) Infected
cells were treated with 4% paraformaldehyde and subjected to surface
immunostaining with a-E2 mabs. C) The medium fraction the infected
cell culture was analyzed by TEM for the presence of VLPs.
doi:10.1371/journal.pone.0025816.g006
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